Results

1–10 of 14 results for Intraocular pressure

The Reservoir Technique for Silicone Oil Placement: Intraocular Pressure Control and Long-Term Outcomes
Kathleen R Schildroth, MD
Annual Meeting Talks
2025
Real-World Intraocular Pressure (IOP) and Glaucoma Outcomes From Intravitreal Treatments Based on Injection Volume
Deepak Sambhara, MD
Annual Meeting Talks
2025
Vials vs Prefilled Syringes (PFS): Intraocular Pressure (IOP) Spikes From 151,657 Intravitreal Injections (IVIs) From 2010 to 2025 From a Single Center in the United Kingdom
Ian Yeung, MA FRCOphth
Annual Meeting Talks
2025
Accuracy and Residual Volume of Commonly Used Syringes for Intravitreal Injection and the Impact on Intraocular Pressure
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2023
Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy
Judy E. Kim, MD, FASRS
Chirag D. Jhaveri, MD, FASRS
Michael S. Ip, MD
Arshad M. Khanani, MD, MA, FASRS
Jordana G Fein, MD, MS
Dennis M. Marcus, MD
Diana V Do, MD, FASRS
Annual Meeting Talks
2024
Faricimab Response is Associated With Intraocular Pressure Lowering in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Tamara L Lenis, MD, PhD, FASRS
Annual Meeting Talks
2024
Intraocular Pressure Elevation Immediately Following High-Volume (0.07 mL-0.15 mL) vs Standard Volume (0.05 mL) Injections
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2024
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Danny A. Mammo, MD
Annual Meeting Talks
2024
Prophylactic Intraocular Pressure–Lowering Measures in Antivascular Endothelial Growth Factor Therapy: Systematic Review and Meta-Analysis
Parnian Arjmand, MD, MSc, FRCSC, DABO
Annual Meeting Talks
2022
Suprachoroidal Use of Triamcinolone Acetonide: Post Hoc Analysis of PEACHTREE to Evaluate Elevations in Intraocular Pressure
On Demand Cases, Courses, and Papers
2022